Fascin expression in endocervical neoplasia: Correlation with tumour morphology and growth pattern

Journal of Clinical Pathology

Volumn 65, Issue 3, 2012, Pages 213-217

  Stewart, Colin J R ^a   Crook, Maxine ^a   Loi, Sarah ^a  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FASCIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL; TUMOR CELL; TUMOR GROWTH; UTERINE CERVIX CARCINOMA IN SITU;

ADENOCARCINOMA; ADENOCARCINOMA, PAPILLARY; CARCINOMA IN SITU; CARRIER PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; PROGNOSIS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84857369464     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200425     Document Type: Article

References (30)

1. Schorge JO, Knowles LM, Lea JS. Adenocarcinoma of the cervix. Curr Treat Options Oncol 2004;5:119-27. (Pubitemid 38915116)
2. Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol 2010;116:140-6.
3. Sasieni P, Castanon A, Cuzick J. Screening and adenocarcinoma of the cervix. Int J Cancer 2009;125:525-9.
4. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology 2002;41:185-207. (Pubitemid 35013941)
5. McCluggage WG. Endocervical glandular lesions: controversial aspects and ancillary techniques. J Clin Pathol 2003;56:164-73. (Pubitemid 36308029)
6. Kindleberger DW, Krane JF, Lee KR. Glandular neoplasia of the cervix. In: Crum CP, Nucci MR, Lee KR, eds. Diagnostic Gynecologic and Obstetric Pathology. 2nd edn. Philadelphia: Elsevier Saunders, 2011:328-78.
7. Stewart CJR, Little L. Diagnostic value and implications of vimentin expression in normal, reactive and neoplastic endocervical epithelium. Pathology 2010;42:217-23.
8. Little L, Stewart CJR. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions. Mod Pathol 2010;23:611-18.
9. Stewart CJR, Crook ML, Little L, et al. Correlation between invasive pattern and immunophenotypic alterations in endocervical adenocarcinoma. Histopathology 2011;58:720-8.
10. Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004;16:590-6. (Pubitemid 39201245)
11. Hashimoto Y, Skacel M, Adams JC. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 2005;37:1787-804. (Pubitemid 40961664)
12. Li A, Dawson JC, Forero-Vargas M, et al. The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion. Curr Biol 2010;20:339-45.
13. Kabukcuoglu S, Ozalp SS, Oner U, et al. Fascin, an actin-bundling protein expression in cervical neoplasms. Eur J Gynaecol Oncol 2005;26:636-41. (Pubitemid 43028059)
14. Stewart CJR, Little L. Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial-mesenchymal transition. Histopathology 2009;55:91-101.
15. Machesky LM, Li A. Fascin. Invasive filopodia promoting metastasis. Commun Integr Biol 2010;3:263-70.
16. Yamashiro S, Yamakita Y, Ono S, et al. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 1998;9:993-1006. (Pubitemid 28457295)
17. Jawhari AU, Buda A, Jenkins M, et al. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 2003;162:69-80. (Pubitemid 36041990)
18. Chen G, Zhang FR, Ren J, et al. Expression of fascin in thyroid neoplasms: a novel diagnostic marker. J Cancer Res Clin Oncol 2008;134:947-51.
19. Wen YH, Yee H, Goswami S, et al. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy. Int J Gynecol Pathol 2009;28:187-92.
20. Daponte A, Kostopoulou E, Minas M, et al. Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancer. Anticancer Res 2008;28:1905-10. (Pubitemid 351892904)
21. Stewart CJR, Crook ML, Manso L. Fascin expression in low-grade uterine endometrioid adenocarcinoma; correlation with MELF type alteration at the deep invasive margin. Histopathology 2011;59:73-80.
22. Grothey A, Hashizume R, Sahin AA, et al. Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 2000;83:870-3.
23. Pelosi G, Pastorino U, Pasini F, et al. Independent prognostic value of fascin immunoreactivity in stage 1 nonsmall cell lung cancer. Br J Cancer 2003;88:537-47. (Pubitemid 36363363)
24. Hashimoto Y, Shimada Y, Kawamura J, et al. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004;67:262-70. (Pubitemid 39551711)
25. Vignjevic D, Schoumacher M, Gavert N, et al. Fascin, a novel target of b-catenin- TCF signalling, is expressed at the invasive front of human colon cancer. Cancer Res 2007;67:6844-53. (Pubitemid 47105531)
26. Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev 2008;18:27-34. (Pubitemid 351694443)
27. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009;28:15-33.
28. Kopfstein L, Christofori G. Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 2006;63:449-68.
29. Lee TK, Poon RT, Man K, et al. Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett 2007;254:308-15. (Pubitemid 47135617)
30. Hayashi Y, Osanai M, Lee GH. Fascin-1 expression correlates with repression of E-cadherin expression in hepatocellular carcinoma cells and augments their invasiveness in combination with matrix metalloproteinases. Cancer Sci 2011;102:1228-35.